Return to homepagePandemic Pact

Irish COVID-19 Vasculopathy Study (iCVS)

  • Funded by HRB Ireland, Irish Research Council
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $234,862.48

  • Funder

    HRB Ireland, Irish Research Council

  • Principal Investigator

    Professor James O'Donnell

  • Research Location

    Ireland

  • Lead Research Institution

    RCSI

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Our recent work shows blood clotting happens in patients with severe COVID-19 infection leading to more deaths. Patients with higher levels of blood clotting were also more likely to require ICU admission. We want to understand why these micro-clots are being formed in the lungs so that more effective treatments for patients with severe COVID-19 can be developed